Impact Factor
3.88
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
5.08
978 total citations
h5-index
43
h5 depth signal
Cited share
75.2%
155 of 206
Total citations
978
Citation footprint
Metric signal
4.95
External metric anchor
Self-citation
0.1%
1 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
China
282
United States
104
Iran
103
Italy
95
India
84
Citing Fields of Research
Phytochemicals
153
Cell Biology
128
Cancer, Autophagy & Apoptosis
105
Diabetes
93
Immunology
90
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
2,521
Articles tracked across the journal lifetime
Indexed publication set
206
155 cited publications
Last 12 months
111
11.1 publications/month
Open access share
29.7%
33 OA publications in the last year
Leading citing country
China
282 citing publications
Leading citing field
Phytochemicals
153 citing publications
Latest tracked publication
30 September 2026
10 recent records available
Coverage & Indexing History
v1n1, 1988-
v1n1, 1988-
Active Coverage
Research Focus & Classification
Indexed Subjects
Cancer, Autophagy & Apoptosis
Immunology
Noncoding RNA
Phytochemicals
Cancer & Development
Aging & Longevity
Cell Biology
Issuing & Sponsoring Bodies
Contributor
International Union of Biochemistry
Broad Categories
Biochemistry
Cancer, Autophagy & Apoptosis
Noncoding RNA
Cancer & Development
Immunology
Aging & Longevity
Neurodegenerative Disorders
Phytochemicals
MeSH Descriptors
Biochemistry
Nutritional Physiological Phenomena
Trace Elements
Vitamins
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1002/biof.70155
Open DOI
KPNβ1 and NKCC1 Modulators as Key Players in HCC : Possible Interventions in Cell Cycle Arrest and Apoptosis
Hepatocellular carcinoma (HCC) remains a major challenge threatening global health. It has a high incidence with poor prognosis, and its response to current conventional therapies is not satisfactory, so we need to explore new effective ...
02
DOI 10.1002/biof.70153
Open DOI
The PTTG1 / AURKA Axis Drives Acquired Anlotinib Resistance in Non‐Small Cell Lung Cancer by Remodeling the Tumor Immune Microenvironment
PTTG1 has been implicated in tumor progression and drug resistance, but its role in acquired anlotinib resistance in non‐small cell lung cancer (NSCLC) remains unclear. This study investigated whether PTTG1 contributes to resistance and ...
03
DOI 10.1002/biof.70152
Open DOI
Clear Cell Carcinoma With Enteroblast‐Like Differentiation Involving Multiple Gynecologic Sites: An Integrated Clinicopathologic, Whole‐Exome, and Transcriptomic Analysis
Clear cell carcinoma with enteroblastic differentiation arising in the female genital tract is exceptionally rare, and its pathogenesis, diagnostic features, and therapeutic implications remain poorly understood. We report a rare case in...
04
DOI 10.1002/biof.70151
Open DOI
Betanin Promotes Wound Closure and Drives a Context‐Specific Transcriptional Repair Program in HaCaT Keratinocytes: A Multi‐Evidence AI ‐Guided Prioritization Study
Keratinocytes coordinate re‐epithelialization, barrier restoration, inflammatory control, and matrix remodeling during cutaneous repair. Although betanin has reported cytoprotective and antioxidant properties, its wound‐relevant transcri...
05
DOI 10.1002/biof.70150
Open DOI
Multi‐Omics‐Enabled Precision Strategies for Overcoming CAR ‐T Therapy Limitations in Gastrointestinal Malignancies
Gastrointestinal malignancies, including gastric cancer, colorectal cancer, hepatocellular carcinoma, and pancreatic ductal adenocarcinoma, remain major causes of cancer‐related morbidity and mortality worldwide. Although chimeric antige...
06
DOI 10.1002/biof.70149
Open DOI
Immune‐Like Malignant Epithelial Programs Shape Tumor–Immune Interactions and Inform Prognostic Stratification in Lung Adenocarcinoma
Lung adenocarcinoma (LUAD) is characterized by marked cellular heterogeneity, yet how malignant epithelial states contribute to immune regulation and clinical outcomes remains incompletely defined. We integrated single‐cell RNA‐sequencin...
07
DOI 10.1002/biof.70136
Open DOI
Multi‐Omics Biomarker Signatures for Precision Diagnosis and Prognosis in Primary Liver Cancer: A Literature Review
Primary liver cancer (PLC) is a biologically heterogeneous group of malignancies dominated by hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (iCCA), and a smaller subset of combined hepatocellular‐cholangiocarcinoma (cHC...
08
DOI 10.1002/biof.70145
Open DOI
Integrated Single‐Cell and Spatial Transcriptomics Reveal SERPINE1 as a Key Link Between Macro_SPP1 Macrophages and Stromal Remodeling in Gastric Cancer
Macrophage heterogeneity is increasingly recognized as an important feature of the gastric cancer tumor microenvironment, yet the macrophage states linked to poor outcome and the molecules connecting them to stromal remodeling remain inc...
09
DOI 10.1002/biof.70162
Open DOI
The Hidden Conductor: HDL –Gut Microbiome Interplay in the Pathophysiology of Inflammatory‐Based Diseases
High‐density lipoprotein (HDL) is a cholesterol transporter that plays a well‐defined role in reverse cholesterol transport. In addition, HDL shows anti‐inflammatory and immunomodulatory functions mainly due to its ability to decrease th...
10
DOI 10.1002/biof.70160
Open DOI
Multifunctional Peptidome Characterization of Ladakh Himalayan Hard Cheese With Comparative Insights From Sikkim
Traditional fermented products of the Indian Himalayas are gaining attention due to their health benefits. Ladakh hard chhurpi (LHC) collected from different altitudes (2784–4523 m) was assessed for antioxidant and ACE inhibitory activit...
Bibliographical & Catalog Notes
Title from cover.
Print issues ceased with v. 36 (2012)
Also issued online.
Vol. 1, no. 1 (1988)19920925 Notice published Printed on acid-free paper